6972-78-7: Linagliptin Nitroso Pyrimidine Impurity

It is an impurity of Linagliptin, which is a long-acting dipeptidyl peptidase-4 inhibitor, which is used as an orally administered agent for type-2 diabetes treatment.

Additional information on CAS 6972-78-7

Catalogue No.

VE007060

CAS No.

6972-78-7

Molecular Formula

C5H6N4O3

Molecular Weight

170.13

Parent drug

Linagliptin

IUPAC Name

6-Amino-1-methyl-5-nitrosopyrimidine-2, 4(1H, 3H)-dione

Synonyms

6-Amino-1-methyl-5-nitroso-2, 4-pyrimidinedione; 6-amino-1-methyl-5-nitroso-uracil; 6-Amino-1-methyl-5-nitrosopyrimidine-2, 4-dione; NSC 62582;

References

Sci-Hub, A capillary electrophoresis method for the determination of the linagliptin enantiomeric impurity, 10.1002/jssc.202000493. (2020). Retrieved December 17, 2021, from Hkvisa.net website: https://sci-hub.hkvisa.net/10.1002/jssc.202000493

Status

In-stock

[rfq_list]

Login first to add product to RFQ List

Request a quote

6972-78-7: Linagliptin Nitroso Pyrimidine Impurity

6972-78-7: Linagliptin Nitroso Pyrimidine Impurity
Catalogue No.

VE007060

CAS No.

6972-78-7

Molecular Formula

C5H6N4O3

Molecular Weight

170.13

Parent drug

Linagliptin

IUPAC Name

6-Amino-1-methyl-5-nitrosopyrimidine-2, 4(1H, 3H)-dione

Synonyms

6-Amino-1-methyl-5-nitroso-2, 4-pyrimidinedione; 6-amino-1-methyl-5-nitroso-uracil; 6-Amino-1-methyl-5-nitrosopyrimidine-2, 4-dione; NSC 62582;

Smiles
References

Sci-Hub, A capillary electrophoresis method for the determination of the linagliptin enantiomeric impurity, 10.1002/jssc.202000493. (2020). Retrieved December 17, 2021, from Hkvisa.net website: https://sci-hub.hkvisa.net/10.1002/jssc.202000493

Status

In-stock

ListName

Linagliptin Nitroso Pyrimidine Impurity

Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url
 
Hidden